Walgreens inks GLP-1 clinical trial deal with major German drugmaker
Healthcare Dive
MAY 3, 2024
Under the deal, Walgreens will find candidates who are overweight or have obesity or diabetes and connect them with a Phase III clinical trial for Boehringer’s GLP-1 drug survodutide.
Let's personalize your content